FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynecology, and can be used to predict the risk of recurrent symptomatic uterine myoma after selective embolization of uterine arteries. That is ensured by establishing a combination of prognostic criteria in the form of a body weight index < 22.3; previous heavy menstrual bleeding and previous hormonal therapy. If the patient with symptomatic uterine myoma has a combination of the above criteria, recurrent myomatous nodes growth is predicted in 78.8 % of cases.
EFFECT: invention provides a personalized approach to choosing a management approach to this category of patients, which in turn reduces the risk of recurrent myomatous nodes and provides good treatment results.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF MYOMATOUS ASSEMBLY EXPULSION FOLLOWING UTERINE ARTERY EMBOLIZATION IN A PATIENT WITH UTERINE MYOMA | 2019 |
|
RU2701210C1 |
| METHOD FOR PREDICTION OF ENDOMETRIAL HYPERPLASIA IN PATIENTS WITH HYSTEROMYOMA FOLLOWING UTERINE ARTERY EMBOLISATION | 2014 |
|
RU2558052C1 |
| METHOD FOR PREDICTION OF SEVERE POST-EMBOLIZATION SYNDROME IN PATIENT WITH UTERINE MYOMA IN EARLY POSTOPERATIVE PERIOD | 2019 |
|
RU2729183C1 |
| METHOD FOR SURGICAL TREATING UTERINE MYOMA | 2002 |
|
RU2223700C1 |
| METHOD FOR PREDICTION OF HYSTEROMYOMA REGRESSION | 2015 |
|
RU2596093C1 |
| METHOD FOR PREDICTING HEMORRHAGES DEVELOPING IN FEMALES SUFFERING FROM HYSTEROMYOMA | 2014 |
|
RU2592374C2 |
| METHOD FOR TRANSRADIAL ENDOVASCULAR EMBOLISATION OF UTERINE ARTERIES | 2014 |
|
RU2551947C1 |
| METHOD FOR COMPLEX CONSERVATIVE TREATMENT OF UTERINE MYOMA | 2016 |
|
RU2632105C1 |
| METHOD FOR TREATING HYPERPLASTIC ENDOMETRIAL PROCESSES COMBINED WITH UTERINE MYOMA | 2006 |
|
RU2317103C1 |
| METHOD FOR TREATMENT OF UTERINE FIBROIDS | 2021 |
|
RU2779190C1 |
